Juan Luis Mosqueda-Gómez

ORCID: 0000-0003-1356-684X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Central Venous Catheters and Hemodialysis
  • Nosocomial Infections in ICU
  • SARS-CoV-2 and COVID-19 Research
  • Clostridium difficile and Clostridium perfringens research
  • Infectious Diseases and Tuberculosis
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Influenza Virus Research Studies
  • Bacterial Identification and Susceptibility Testing
  • HIV, Drug Use, Sexual Risk
  • Immune Cell Function and Interaction
  • Tuberculosis Research and Epidemiology
  • Antibiotics Pharmacokinetics and Efficacy
  • Hepatitis C virus research
  • Antibiotic Use and Resistance
  • Vaccine Coverage and Hesitancy
  • Surgical site infection prevention
  • Antibiotic Resistance in Bacteria
  • Virology and Viral Diseases
  • Bacillus and Francisella bacterial research
  • Pneumonia and Respiratory Infections
  • Poxvirus research and outbreaks
  • Peripheral Neuropathies and Disorders

Hospital Regional de Alta Especialidad del Bajío
2011-2025

Universidad de Guanajuato
2013-2024

Secretaria de Salud
2024

Universidad de León
2016-2022

Instituto Tecnológico de León
2019

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
2003-2015

Instituto Nacional de Salud Pública
2015

AbbVie (United States)
2015

Cornell University
2015

To compare the efficacy of efavirenz (EFV) vs lopinavir/ritonavir (LPV/r) in combination with azidothymidine/lamivudine antiretroviral therapy naive, HIV+ individuals presenting for care CD4 counts <200/mm.Prospective, randomized, open label, multicenter trial Mexico. HIV-infected subjects <200/mm were randomized to receive label EFV or LPV/r plus (fixed-dose combination) 48 weeks. Randomization was stratified by baseline cell count (< =100 >100/mm). The primary endpoint percentage patients...

10.1097/qai.0b013e3181cae4a1 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2010-03-18

ObjectivesTo study the prevalence, risk factors, outcome, and molecular epidemiology in patients with bacteremia caused by extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae (Kp) (cases), comparison a susceptible Kp (controls).MethodsThis was retrospective case–control including all episodes of for period 1993 to 2002 at referral hospital adults Mexico. ESBL production tested E-test. All isolates were typed pulsed field gel electrophoresis (PFGE). A subset underwent plasmid...

10.1016/j.ijid.2008.03.008 article EN publisher-specific-oa International Journal of Infectious Diseases 2008-06-04

Antiretroviral therapies have proved life-saving in HIV infection, dramatically reducing morbidity and mortality.With longer survival, morbidities mortalities infection are increasingly similar to the associated with ageing.In treated risk of these is linked immune activation, inflammation coagulation indices.And persons failure restore circulating CD4 T cell numbers a greater as well heightened levels coagulation.The drivers incompletely defined could be related sustained low viral...

10.7448/ias.18.3.20145 article EN cc-by Journal of the International AIDS Society 2015-04-16

We studied the prevalence of HIV, syphilis, hepatitis B virus (HBV), and C (HCV) infection associated risk behaviors in prison state system Guanajuato, Mexico between September 2011 February 2012. Blood samples were drawn from adult inmates all State prisons who agreed to participate this cross-sectional study. Data on collected by using self-administered questionnaires. The HBV, HCV was 0.6% [95% confidence interval (CI) = 0.2–1.1], 0.7% (95% CI 0.4–1.0), 0.4 0.04–0.74), 4.8 3.6–5.9),...

10.1089/aid.2016.0271 article EN AIDS Research and Human Retroviruses 2017-01-17

To estimate the prevalence of HCV-infection and identify associated factors among inmates in State Prison System Guanajuato Mexico (Sep-2011 to Feb-2012).Cross-sectional, observational study 10 prisons (2011-2012). We offered HCV-testing applied audio computer-assisted self-interviews all adults imprisoned System. used a complex survey analysis distribution variables its corresponding 95% confidence intervals, taking into consideration expected cluster effect by common characteristics within...

10.1371/journal.pone.0179931 article EN cc-by PLoS ONE 2017-06-27

The 2009-2010 influenza A (H1N1pdm09) pandemic caused substantial morbidity and mortality among young patients; however, estimates have been confounded by regional differences in eligibility criteria inclusion of selected populations. In 2013-2014, H1N1pdm09 became North America's dominant seasonal strain. Our objective was to compare the baseline characteristics, resources, treatments with outcomes critically ill patients Mexican Canadian hospitals 2014 using consistent...

10.1097/ccm.0000000000001830 article EN Critical Care Medicine 2016-07-14

Carbapenem-resistant Gram-negative bacilli (CR-GNB) are a major public health concern. We aimed to evaluate the prevalence of CR-GNB and frequency carbapenemase-encoding genes in tertiary referral center from El Bajio, Mexico. A cross-sectional study was conducted between January October 2022; (GNB) were screened for vitro resistance at least one carbapenem. further analyzed carbapenemase-production through phenotypical methods by real-time PCR following genes: blaKPC, blaGES, blaNDM,...

10.3390/antibiotics12081295 article EN cc-by Antibiotics 2023-08-08

Background: People who live with HIV (PWLH) have been one of the most affected groups during current mpox outbreak. They are hypothesized to a more severe clinical course than people without but comparative data is scarce. We aimed compare features and outcomes in Mexico. Setting: Country-wide study Methods: performed an observational using nation-wide epidemiological data. included all confirmed diagnosed between May November 2022 Clinical sociodemographic characteristics were compared HIV....

10.1097/qai.0000000000003407 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2024-03-04
María Noemí Carnalla-Barajas Araceli Soto‐Noguerón Miguel Ángel Sánchez-Alemán Fortino Solórzano‐Santos María Elena Velázquez-Meza and 65 more Gabriela Echániz‐Aviles Francisco Márquez-Díaz Lucila Martínez‐Medina María Elizabeth Olvera-Herrera Marı́a Guadalupe Miranda-Novales Martha Camacho-Velázquez José Guillermo Vásquez-Rosales Rosario Vázquez-Larios Eduardo Rivera-Martínez Ana María del Rocío Hernández-Dueñas Briceida López‐Martínez Sarbelio Moreno-Espinoza Ernesto Calderón-Jaimes Yolanda Jiménez-Tapia José Luis Arredondo-Garcı́a Mercedes Macías-Parra Patricia Arzate-Barbosa Napoleón González Saldaña José Sifuentes‐Osornio Alfredo Ponce‐de‐León Ana Lilia Rolón-Montes de Rosa Areli Martínez‐Gamboa Patricia Volkow-Fernández Patricia Cornejo‐Juárez José Manuel Feliciano-Guzmán Ismelda López-Ovilla Juan Manuel Barajas-Magallón Jorge Vázquez-Narváez Alejandra Cendejas-Amezcua María del Rosario Magaña-Miranda Andrés Flores Santos Martín Magaña-Aquino Antonio Luévanos-Velázquez Rayo Morfín‐Otero Eduardo Rodríguez-Noriega Sergio Esparza-Ahumada Guadalupe Atilano-Durán Norma de la Re-Montaño Martha Anchondo-Martínez Jesús Contreras-Soto Ana Dolores Quintero-Grijalva Jacobo Ayala-Aguilar Claudia Elena Guajardo-Lara Elvira Garza‐González oaquín Rincón-Zuno Domingo Sánchez-Francia Verónica Andrade-Almaraz Reyna Edith Corte-Rojas María del Socorro Gutierrez-Rodríguez Socorro Azarell Anzurez-Gutiérrez Juan Luis Mosqueda-Gómez Mariana Gil-Veloz Javier Castellanos-Martínez Juan Carlos Tinoco-Fávila Lorena Salcido-Gutiérrez Rosalía Jarillo-Medina Jessica Paola-Purizaca Bazán Dinora Aguilar-Escobar Ana Rosa Méndez-Cruz Leova Pacheco-Gil Edgardo S. Acevedo-Casarrubias Alma Rosa González-Hernandez María del Carmen Alvarez Molina Manuel Ibarra-Muñiz Paul Mora-Dominguez

Introduction of pneumococcal conjugate vaccines (PCV) targeted against a limited number serotypes substantially decreased invasive (IPD) and non-invasive diseases (NIPD) but it was accompanied by non-vaccine type replacement disease. After 9 years introduction PCV in Mexico, we analyze the evidence indirect effects on IPD NIPD serotype distribution among groups not to receive vaccine.From January 2000 December 2014, strains isolated from cases patients ≥5 age participant hospitals SIREVA II...

10.1016/j.ijid.2017.02.005 article EN cc-by-nc-nd International Journal of Infectious Diseases 2017-02-17
Santiago Ávila‐Ríos Claudia García‐Morales Marisol Valenzuela-Lara Antoine Chaillon Daniela Tapia‐Trejo and 90 more Marissa Pérez‐García Dulce María López-Sánchez Liliana Maza-Sánchez Silvia J del Arenal-Sánchez Héctor E. Paz‐Juárez Verónica S Quiroz‐Morales Sanjay R. Mehta Davey M. Smith Eddie A León-Juárez Carlos Magis‐Rodríguez Gustavo Reyes‐Terán Jorge A Gamboa-Marroquín Alan F Espinoza-Fernández Mario Lam-Enríquez Oscar A Castillo-Soria Samuel Navarro-Álvarez Noemí Varela-Lara Rogelio Ortiz-Batanero Andrés Flores-Gómez Luis Velasco-Robledo Arturo Alatorre-Manjarrez Rita E Gutiérrez-Zúñiga Jesús Peña-Gutiérrez Alejandro Rivera-Marroquín B. Zapico Robles Maribel Gálvez-Martínez Raúl Hernández-Gutiérrez David Solís-Grajales María G Mora-Castellanos Manuel Vidal-López Maribel A González-Pacheco Carmen Salazar-Pérez Juan C A Padilla-Acosta Andrea González‐Rodríguez Florentino Badial‐Hernández José C Tecalero-Hernández Patricia G García-Martínez Arturo Cendejas-Hernández Juan Luis Mosqueda-Gómez José M Benítez-Carrasco J Bello Benjamín Fierro-Teliz Jazmín Arellano-Torreblanca Ramiro Manríquez-Gómez Elizabeth Zaragoza-Zapata Saúl O Ruiz-Torrez Luz Alicia González-Hernández Raúl Soria-Rodríguez Nora P. Quintero-Perez Gerardo Amaya‐Tapia Juana Arredondo-Fuentes Javier Santiesteban-Garay María S Mendoza-García Gustavo Durán-Arias Margarita M Rosas-Dossetti Juana C Chacón-Sánchez Angélica Uribe-Iturbide Pedro Castro-Melchor Luis G Castillo-Reyna Lesvia M. Rivera-Abarca Jorge E de la Cruz-Castillo Elizabeth Papaqui-Limón María P Velázquez-Esqueda Alexandra S Domínguez-Sánchez Zoila Magdaleno-Sandoval Jorge Silva-Herrera Mario A. Esparza-Pérez Alejandro Muñoz-Doana Gabriela Aldapa Fernando Arrollo-Romero Sergio A Salazar-Arriola Elva C Vásquez-Bañuelos Mario J Hernández-Morales Daniel Prado-Rosas Mercedes Santos-Villegas Esteban Sánchez-Hernández Adonay Jiménez-Jiménez Alejandro Cárdenas-Anzures Juan F Ortiz-Brisuela Juana Díaz-García Carlos A Carrillo-Garza Juan Beltrán-Saldaña Santos Sánchez-Rivas Lizbeth Domínguez-Ramírez Jorge M. de la Roca-Chiapas Hilda Basilio-Badillo Uri Torruco-García Juan A Pérez-Alonso Luis E Arias-Tlacuilo Omar Palacios-Lara

HIV pretreatment drug resistance (PDR) to NNRTIs in persons initiating ART is increasing Mexico.

10.1093/jac/dky512 article EN Journal of Antimicrobial Chemotherapy 2018-11-18

Current results do not provide conclusive evidence on the effect of BCG vaccination COVID-19 alone or in combination with other factors. To address this limitation, study we used a citizen science initiative pandemic to collect data worldwide during 2 October 2020–30 2020 (1,233 individuals) structured way for analysing factors and characteristics affected individuals relation vaccination. For first time, our suggested that may increase risk at certain age, particularly vaccinated childhood....

10.1111/tbed.14097 article EN Transboundary and Emerging Diseases 2021-04-07

We aimed to determine the effectiveness of switching bictegravir in maintaining an undetectable viral load (<50 copies/mL) among people with HIV (PWH) as compared continuing dolutegravir-, efavirenz-, or raltegravir-based antiretroviral therapy using nationwide observational data from Mexico. emulated 3 target trials comparing vs dolutegravir, efavirenz, raltegravir. Eligibility criteria were PWH aged ≥16 years a <50 copies/mL and at least months current (dolutegravir, raltegravir) between...

10.1093/ofid/ofae446 article EN cc-by Open Forum Infectious Diseases 2024-07-30

Summary Background Skin redness is a common cosmetic concern affecting predominantly fair‐skin individuals and often leading to rosacea. On the basis of current scientific knowledge physiological mechanisms underlying problem, complex integral skin care serum (100RXED2025) was developed tested clinically for efficacy. Method Forty‐five healthy men women volunteers, age 30–65, were recruited. All subjects had fair (phototype I, II, or III) presented some degree with telangiectasia on cheeks,...

10.1111/j.1473-2165.2012.00623.x article EN Journal of Cosmetic Dermatology 2012-09-01
Coming Soon ...